InfuSystem (NYSE:INFU) versus SANUWAVE Health (OTCMKTS:SNWV) Head-To-Head Contrast

SANUWAVE Health (OTCMKTS:SNWV) and InfuSystem (NYSE:INFU) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, dividends, risk, institutional ownership and earnings.

Analyst Ratings

This is a breakdown of current recommendations and price targets for SANUWAVE Health and InfuSystem, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SANUWAVE Health	0	0	0	0	0.00
InfuSystem	0	1	2	2	3.20

InfuSystem has a consensus target price of $14.50, indicating a potential upside of 61.83%. Given InfuSystem’s stronger consensus rating and higher possible upside, analysts plainly believe InfuSystem is more favorable than SANUWAVE Health.

Profitability

This table compares SANUWAVE Health and InfuSystem’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SANUWAVE Health	-1.33%	-23.83%	-20.60%
InfuSystem	1.12%	2.78%	1.41%

Valuation & Earnings

This table compares SANUWAVE Health and InfuSystem”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SANUWAVE Health	$41.28 million	6.23	-$25.81 million	($1.30)	-23.06
InfuSystem	$141.05 million	1.29	$870,000.00	$0.26	34.46

InfuSystem has higher revenue and earnings than SANUWAVE Health. SANUWAVE Health is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

42.5% of SANUWAVE Health shares are held by institutional investors. Comparatively, 71.1% of InfuSystem shares are held by institutional investors. 14.9% of SANUWAVE Health shares are held by company insiders. Comparatively, 11.4% of InfuSystem shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Volatility & Risk

SANUWAVE Health has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500. Comparatively, InfuSystem has a beta of 1.71, indicating that its share price is 71% more volatile than the S&P 500.

Summary

InfuSystem beats SANUWAVE Health on 13 of the 15 factors compared between the two stocks.

About SANUWAVE Health

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's pulsed acoustic cellular expression systems, including dermaPACE system for treating diabetic foot ulcers and other chronic wounds; orthoPACE system for treating tendinopathies and acute and nonunion fractures; and Profile is used to provide solution for pain management in sports medicine and physical therapy. Its portfolio of wound treatment solutions provides patients with a noninvasive technology that boosts the body's normal healing and tissue regeneration processes. In addition, the company offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds. SANUWAVE Health, Inc. was founded in 2004 and is headquartered in Eden Prairie, Minnesota.

About InfuSystem

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.